TNF and inflammatory bowel disease: For instance, on the basis of data from a systematic review of the literature, suggestions of continuing anti-TNF-α therapies throughout pregnancy in pregnant IBD patients and switching to anti-TNF-α therapies in pregnant IBD patients who have a disease flare with other therapies have been made [41].